Texas Oncology Pharmacy North Arlington is an authorized DME supplier for medicare equipments and products.
Texas Oncology Pharmacy North Arlington is a Community/Retail Pharmacy in Arlington, Texas. This pharmacy is owned and operated by Oncology Pharmacy Services, Inc. This organization is also known as sub part of Oncology Pharmacy Services, Inc. It is located at 906 W Randol Mill Rd Ste 200, Arlington and it's customer support contact number is 817-664-9650. The authorized person of Texas Oncology Pharmacy North Arlington is J Ernest Sims who is Director, Contract Administration of the pharmacy and his contact number is 972-490-2912.Texas Oncology Pharmacy North Arlington accepts medicare which means medicare covered patients will not be billed for any more than the Medicare deductible and coinsurance. Texas Oncology Pharmacy North Arlington is a pharmacy where pharmacists store, prepare, and dispense medicinal preparations and/or prescriptions for a local patient population in accordance with federal and state law; counsel patients and caregivers (sometimes independent of the dispensing process); administer vaccinations; and provide other professional services associated with pharmaceutical care such as health screenings, consultative services with other health care providers, collaborative practice, disease state management, and education classes.
Pharmacy Details:
Texas Oncology Pharmacy North Arlington type, location, contact phone number and fax are as below. Patients can directly walkin to the pharmacy or can call on the below given customer support phone number for enquiries.
Name:
Texas Oncology Pharmacy North Arlington
Type:
Community/Retail Pharmacy
Location:
906 W Randol Mill Rd Ste 200, Arlington, Texas, 76012-2510
Phone:
817-664-9650
Fax:
817-664-9655
Authorized/Official Person Profile:
Officially authorized person to contact for any management issues or complaints of this pharmacy is as below. Person's position and contact details are also mentioned below.
Name:
J Ernest Sims
Position:
Director, Contract Administration
Contact Number:
972-490-2912
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of given pharmacy are as mentioned below.
NPI Number:
1841611316
Parent Organization:
Oncology Pharmacy Services, Inc
NPI Enumeration Date:
30 Dec, 2013
NPI Last Update On:
10 Oct, 2020
Medical Licenses:
Organizations can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Texas Oncology Pharmacy North Arlington are as mentioned below.
Specialization
License Number
State
Status
Community/Retail Pharmacy
Primary
Pharmacy
28825
Texas
Secondary
Other Medical Identifiers:
Other legacy medical identifiers of the pharmacy such as Medicaid, Medicare PIN, NSC, UPIN etc. are mentioned as below.
Identifier
Type
State
Issuer
5910650
Other
Ncpdp
Medicare Enrollment:
Texas Oncology Pharmacy North Arlington is enrolled in medicare and it's Pac Id, enrollment Id, registered name and type is as stated below.
PAC ID:
Enrollment ID:
Org Name
Medicare Entity Type
6002937190
O20140624000724
Oncology Pharmacy Services Inc
DME SUPPLIER - PHARMACY
Products Available:
Texas Oncology Pharmacy North Arlington has following products available for sale under medicare.
Products
Infusion Pumps & Supplies: External Infusion
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Po Box 731145, Dallas, Texas
Zip:
75373-1145
Phone Number:
972-997-8103
Fax Number:
469-467-2535
Patients can reach Texas Oncology Pharmacy North Arlington at 906 W Randol Mill Rd Ste 200, Arlington, Texas or can call on customer care at 817-664-9650.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.